Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
Titel:
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
Auteur:
Corominas, Júlia Garriga, Carme Prenafeta, Antoni Moros, Alexandra Cañete, Manuel Barreiro, Antonio González-González, Luis Madrenas, Laia Güell, Irina Clotet, Bonaventura Izquierdo-Useros, Nuria Raïch-Regué, Dàlia Gallemí, Marçal Blanco, Julià Pradenas, Edwards Trinité, Benjamin Prado, Julia G. Blanch-Lombarte, Oscar Pérez-Caballero, Raúl Plana, Montserrat Esteban, Ignasi Pastor-Quiñones, Carmen Núñez-Costa, Xavier Taleb, Rachel Abu McSkimming, Paula Soriano, Alex Nava, Jocelyn Anagua, Jesse Omar Ramos, Rafel Lluch, Ruth Martí Comes, Aida Corpes Romero, Susana Otero Gomez, Xavier Martinez Sans-Pola, Carla Moltó, José Benet, Susana Bailón, Lucía Arribas, Jose R. Borobia, Alberto M. Parada, Javier Queiruga Navarro-Pérez, Jorge Forner Giner, Maria José Lucas, Rafael Ortí Jiménez, María del Mar Vázquez Compán, Salvador Oña Alvarez-Mon, Melchor Troncoso, Daniel Arana-Arri, Eunate Meijide, Susana Imaz-Ayo, Natale García, Patricia Muñoz de la Villa Martínez, Sofía Fernández, Sara Rodríguez Prat, Teresa Torroella, Èlia Ferrer, Laura